Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.99+0.07 (+8.07%)
Close on Nov 18, 2026Market cap $51.51MP/E –Yield –
Rafael net income
Net income is the profit left for shareholders after every expense, interest and tax.
Rafael's net income for the twelve months ending Jul 31, 2026 was -$29.64M. For fiscal 2026 it was -$29.64M. The highest annual figure on record is $710.00K in fiscal 2016.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -$29.64M | – |
| FY2025 | Jul 31, 2025 | -$30.52M | – |
| FY2024 | Jul 31, 2024 | -$34.41M | – |
| FY2023 | Jul 31, 2023 | -$1.88M | – |
| FY2022 | Jul 31, 2022 | -$124.66M | – |
| FY2021 | Jul 31, 2021 | -$23.06M | – |
| FY2020 | Jul 31, 2020 | -$10.75M | – |
| FY2019 | Jul 31, 2019 | -$4.69M | – |
| FY2018 | Jul 31, 2018 | -$11.65M | -8541.3% |
| FY2017 | Jul 31, 2017 | $138.00K | -80.6% |
| FY2016 | Jul 31, 2016 | $710.00K | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -$9.18M | – |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | -$4.23M | – |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | -$6.42M | – |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | -$9.82M | – |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | -$290.00K | – |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | -$4.78M | – |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | -$4.64M | -176.7% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | -$9.01M | – |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | -$4.47M | -466.5% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -$32.35M | – |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $6.05M | – |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | -$3.64M | -328.5% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $1.22M | -90.5% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | -$1.44M | – |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | -$3.25M | – |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | $1.59M | – |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | $12.87M | – |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -$5.55M | – |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -$2.06M | – |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -$128.87M | – |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | -$10.74M | – |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -$2.65M | – |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -$8.24M | – |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -$1.43M | – |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | -$5.74M | – |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | -$2.16M | – |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -$1.25M | – |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -$1.60M | – |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -$2.19M | – |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -$1.01M | – |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -$1.02M | – |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -$481.00K | – |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -$635.00K | – |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -$531.00K | – |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | -$546.00K | -428.9% |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -$9.33M | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | -$91.00K | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -$65.00K | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | $166.00K | – |
See a number that looks wrong?